NCT01835483View on ClinicalTrials.gov

Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test

CompletedOBSERVATIONAL
Enrollment

867

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Factor V LeidenFactor IIThrombosis
Trial Locations (3)

49503

Sequenom Center for Molecular Medicine, Grand Rapids

77030

The Methodist Hospital Research Institute, Houston

97239

Oregon Health & Science University, Portland

All Listed Sponsors
lead

Sequenom, Inc.

INDUSTRY

NCT01835483 - Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test | Biotech Hunter | Biotech Hunter